C
Commodore Capital LP
+ HältJATT
+40.77%
3-Monats-Rendite
$10.340
+0.091 (+0.88%)Zum Schluss
Loading chart…
- Hoch
- 10.340
- Eröffnung
- 10.275
- Volumengewichteter Durchschnittskurs
- 10.32
- Volumen
- 658.00
- Marktkap.
- —
- Tief
- 10.275
- Umsatz
- 6.79K
- EV/EBITDA, TTM
- 0.00
JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue.
KI-Analyse of JATT II Acquisition Corp (JATT)
HaltenCurrently, Zura Bio Ltd (JATT) is not a strong buy due to its low price performance and negative earnings. The stock is trading at $10.25, which is only 1.9% above its 52-week low of $9.99. Additionally, the RSI is at 35.681, indicating that the stock is approaching oversold territory but is not yet a clear buy signal. The forward P/E ratio is 0, showing no expected earnings growth, which raises concerns about its profitability.
Bewertungskennzahlen
Das aktuelle erwartete KGV von JATT II Acquisition Corp (JATT) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von .
Whales, die JATT halten
Event-Zeitleiste
News
8.508-27NewsfilterJATT III Acquisition Corp Successfully Completes IPO
- 8.508-25Newsfilter
JATT III Acquisition Corp Prices Initial Public Offering
8.506-29PRnewswireTalawar and JATT II Announce Business Combination Agreement
- 8.506-29Newsfilter
Talawar and JATT II Announce Business Combination Agreement
- 8.504-20Newsfilter
JATT II Acquisition Corp Successfully Completes IPO
JATT FAQ – beantwortet von Alphio AI
JATT II Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with the Company. The Company is not engaged in any business operations and has not generated any revenue. It operates in the Financials sector.
Currently, Zura Bio Ltd (JATT) is not a strong buy due to its low price performance and negative earnings. The stock is trading at $10.25, which is only 1.9% above its 52-week low of $9.99. Additionally, the RSI is at 35.681, indicating that the stock is approaching oversold territory but is not yet a clear buy signal. The forward P/E ratio is 0, showing no expected earnings growth, which raises concerns about its profitability.
Community
Mehr ↗Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenÄhnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.